Alzheimer’s quick OK, take two: FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval https://ift.tt/zqJpe5W John Carroll via Endpoints https://endpts.com July 6, 2022
Biogen-Eisai go for another biomarker approval in Alzheimer’s with lecanemab—and snag priority review
Biogen-Eisai go for another biomarker approval in Alzheimer’s with lecanemab—and snag priority review https://ift.tt/31eRatO aarmstrong via FierceBiotech https://ift.tt/Pi7lFbr July 6, 2022 at 01:34AM
Evidence Based Guide launched focused on digital transformation
Evidence Based Guide launched focused on digital transformation https://ift.tt/8scbtv4 via MedTech News https://ift.tt/J7Ot5Sr July 6, 2022 at 01:05AM
Robotic Surgery Company Memic Rebrands as Momentis
Robotic Surgery Company Memic Rebrands as Momentis https://ift.tt/4cbskBS Amanda Pedersen via MDDI Online https://ift.tt/7YHEo0v July 5, 2022 at 11:55PM
Drugmaker 340B contract pharmacy restrictions continue with Bausch Health
Drugmaker 340B contract pharmacy restrictions continue with Bausch Health https://ift.tt/gyHWv5L rking via All Stories https://ift.tt/QUxgvRk July 5, 2022 at 11:47PM
Report: These are the factors impacting individual, small group premiums in 2023
Report: These are the factors impacting individual, small group premiums in 2023 https://ift.tt/ZeVYs6W pminemyer via All Stories https://ift.tt/QUxgvRk July 5, 2022 at 10:24PM